News

Viewing Page 1 of 1 | Showing Results 1 - 9 of 9

A bright new future for people with Hep C

June 27, 2017
Hepatitis C can cause serious liver problems, cirrhosis, cancer and death. It used to be nearly incurable. New medications can cure the disease, allowing people with Hep C to have a healthy, hepatitis-free future.


New milestone for Swedish liver transplant program

March 23, 2017
The Swedish Transplant Program recently performed its 100th liver transplant, another milestone in our mission to save lives and treat liver disease in the Pacific Northwest. Since the Swedish Liver Transplant Program began in 2010, it has grown to serve patients across Washington, Alaska, Montana and Idaho. Today, it’s the No. 1 transplant program in the region based on quality and outcomes.

The silent epidemic of viral hepatitis

November 01, 2016

Approximately 3.5 to 5.3 million Americans are infected with viral hepatitis, but most people do not know they are part of a silent epidemic. This puts them at greater risk of developing severe complications of hepatitis and more likely to spread the virus to others. That’s why the federal government has called on certain groups of Americans to get tested for chronic forms of hepatitis and, if needed, undergo treatment.

Liver disease and acetaminophen: can you take it safely?

June 06, 2016
Doctors often tell patients with liver disease that they shouldn't use acetaminophen, a common over-the-counter pain reliever. Acetaminophen is broken down by the liver and can form byproducts that are toxic to the liver, so this warning is not completely without merit. But take it from a hepatologist, acetaminophen is the best option for pain relief for people with liver disease. Read on to learn why.

Liver cancer screening: Overcoming a silent killer

February 17, 2016

Preventive care is a crucial aspect of chronic liver disease management, and liver cancer screening is a top priority. Liver cancer (hepatocellular carcinoma) is the third-leading cause of cancer-related deaths worldwide, and its incidence is expected to rise in the United States in coming years. So who should be screened for liver cancer, how do we make the diagnosis and what treatment options are available?

Why are some people turned down for a liver transplant

August 12, 2015
The decisions of a liver transplant program can sometimes seem unfair or even arbitrary, especially when a loved one is turned down for a liver transplant. While everyone in need of a transplant deserves an opportunity to be evaluated, not everyone can be placed on the waiting list. 

Why Have a Day Dedicated to Hepatitis?

July 28, 2015
Viral hepatitis is the most common cause of chronic liver disease worldwide. In fact, the two most common forms, hepatitis B (HBV) or hepatitis C (HCV), infect over 500 million people around the world – compared to 31 million with HIV. Chronic HBV is the most common cause of viral hepatitis followed by HCV. These two viruses are responsible for up to 2 million deaths a year. Therefore, it makes sense to call attention to this important global issue and this is why July 28 is World Hepatitis Day.

Fatty Liver Disease in Children: It's About Sugar, Not Fat!

July 08, 2015

It’s common knowledge that over the last few decades there has been a significant increase in the number of children with obesity in the U.S. One of the complications of obesity is a condition termed metabolic syndrome, which consists of the combination of high cholesterol, blood sugar, blood pressure, and waist circumference. Having metabolic syndrome has long been a well-known risk factor for heart disease, but less known is the relationship between obesity, metabolic syndrome and liver disease.

As a pediatric specialist who treats children with liver diseases, I am often asked to see children with a condition called “fatty liver disease.” In fatty liver disease, fat accumulates within the liver as a direct result of obesity and metabolic syndrome. The curious thing about this type of liver disease, however, is that it is identical to the liver disease seen in alcoholics.

Internationally renowned hepatologist, researcher named director of Swedish liver care network

September 25, 2014

Kris Kowdley, M.D., also named research director of the Swedish Organ Care Program

SEATTLE — Sept. 25, 2014 —Internationally renowned physician and researcher Kris V. Kowdley, M.D., FACP, FACG, AGAF and AASLD Fellow has joined the Swedish Liver Center’s medical staff as Director of the Swedish Liver Care Network and Research Director of the Organ Care Program. Dr. Kowdley will provide transplant and liver care for patients while continuing his groundbreaking research into Hepatitis C. Dr. Kowdley’s first day at Swedish was Sept. 15.

“We are delighted to welcome Dr. Kowdley to the Swedish Liver Center medical staff,” said Marquis Hart, M.D., director of the Swedish Organ Transplant Program. “Dr. Kowdley’s ambitious research is giving hope to patients with serious liver disease and we are excited to extend his care to our patients.”

Prior to Swedish, Dr. Kowdley served as the director of the Liver Center of Excellence and the director of research at the Digestive Disease Institute at Virginia Mason Medical Center in Seattle.

Viewing Page 1 of 1 | Showing Results 1 - 9 of 9